Compare SFL & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFL | INSP |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2004 | 2018 |
| Metric | SFL | INSP |
|---|---|---|
| Price | $12.47 | $40.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | $12.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | ★ 7.05% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | $13.07 | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $6.73 | $41.52 |
| 52 Week High | $12.94 | $152.36 |
| Indicator | SFL | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 69.20 | 27.58 |
| Support Level | $10.57 | N/A |
| Resistance Level | N/A | $59.40 |
| Average True Range (ATR) | 0.33 | 2.74 |
| MACD | 0.08 | -1.04 |
| Stochastic Oscillator | 72.29 | 3.06 |
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities. The company operates as a single reportable segment, generating revenue from long-term, fixed-rate charters. Its Additional revenue sources include sales-type lease interest income, voyage charter and pool revenues, and drilling contract revenues.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.